Article
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
The Journal of biological chemistry - 12 Sept 2008
Quintanilla Rodrigo A, Jin Youngnam N, Fuenzalida Karen, Bronfman Miguel, Johnson Gail V W
Abstract excerpt
Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a member of the PPAR family of transcription factors. Synthetic PPARgamma agonists are used as oral anti-hyperglycemic drugs for the treatment of non-insulin-dependent diabetes. However, emerging evidence indicates that PPARgamma act...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.